AKCEA THERAPEUTICS INC's ticker is AKCA and the CUSIP is 00972L107. A total of 100 filers reported holding AKCEA THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 1.70 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $408,000 | +15.9% | 22,512 | -12.3% | 0.00% | 0.0% |
| Q2 2020 | $352,000 | +43.7% | 25,672 | +49.7% | 0.00% | 0.0% |
| Q1 2020 | $245,000 | -14.9% | 17,151 | +0.7% | 0.00% | – |
| Q4 2019 | $288,000 | +11.2% | 17,024 | +1.1% | 0.00% | – |
| Q3 2019 | $259,000 | -34.9% | 16,840 | -0.7% | 0.00% | -100.0% |
| Q2 2019 | $398,000 | -18.1% | 16,965 | -1.1% | 0.00% | 0.0% |
| Q1 2019 | $486,000 | -3.8% | 17,159 | +2.4% | 0.00% | 0.0% |
| Q4 2018 | $505,000 | +25.0% | 16,750 | +45.1% | 0.00% | 0.0% |
| Q3 2018 | $404,000 | +39.3% | 11,542 | -5.7% | 0.00% | 0.0% |
| Q2 2018 | $290,000 | -13.4% | 12,246 | -6.3% | 0.00% | 0.0% |
| Q1 2018 | $335,000 | +70.1% | 13,064 | +14.9% | 0.00% | – |
| Q4 2017 | $197,000 | -44.2% | 11,369 | -10.9% | 0.00% | -100.0% |
| Q3 2017 | $353,000 | – | 12,762 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 2,389,571 | $61,197,000 | 1.69% |
| Virtus ETF Advisers LLC | 39,351 | $1,008,000 | 0.88% |
| Eventide Asset Management | 175,000 | $4,482,000 | 0.21% |
| ALTRINSIC GLOBAL ADVISORS LLC | 187,800 | $4,810,000 | 0.19% |
| Bellevue Group AG | 48,799 | $1,250,000 | 0.12% |
| Perceptive Advisors | 97,144 | $2,488,000 | 0.07% |
| FMR LLC | 10,008,016 | $256,306,000 | 0.03% |
| WELLINGTON MANAGEMENT GROUP LLP | 3,384,101 | $86,667,000 | 0.02% |
| Virtu Financial LLC | 12,571 | $322,000 | 0.02% |
| Cubist Systematic Strategies, LLC | 7,843 | $201,000 | 0.01% |